Esen K. Akpek

Dr. Esen K. Akpek

Allergy and Immunology
2351 Erwin Rd, 
Durham, NC 
On Staff At
Accepting New Patients
2351 Erwin Rd, 
Durham, NC 
OverviewInsuranceLocationsClinical Research

Overview

Esen Akpek is an Allergy and Immunologist in Durham, North Carolina. Dr. Akpek is rated as an Experienced provider by MediFind in the treatment of Glaucoma. Her top areas of expertise are Conjunctivitis (Pink Eye), Giant Papillary Conjunctivitis, Scleritis, Vitrectomy, and Cataract Removal. Dr. Akpek is currently accepting new patients.

Her clinical research consists of co-authoring 158 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Allergy and Immunology
Licenses
Ophthalmology in MD
Fellowships
Cornea and External Diseases, Johns Hopkins University (Maryland), Ocular Immunology and Uveitis, Massachusetts Eye & Ear Infirmary
Hospital Affiliations
Duke University Hospital
Languages Spoken
English
French
Turkish
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Duke Eye Center
2351 Erwin Rd, Durham, NC 27705

Additional Areas of Focus

Dr. Akpek has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Uveitis
Scleritis

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus
Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus
Enrollment Status: Completed
Publish Date: March 07, 2025
Intervention Type: Drug
Study Phase: Phase 4
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
A Phase I/II Prospective, Randomized, Multicenter, Double-Masked, Vehicle-Controlled Clinical Trial to Evaluate the Safety and Efficacy of Corneal Collagen Cross-Linking of Keratoprosthesis Carrier Tissue in High-Risk Keratoprosthesis Implantation
Enrollment Status: Completed
Publish Date: May 10, 2023
Intervention Type: Drug, Device
Study Phase: Phase 1/Phase 2
View 1 Less Clinical Trial

158 Total Publications

TFOS DEWS III.
TFOS DEWS III.
Journal: American journal of ophthalmology
Published: November 23, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Akpek's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile